{"name":"Spyre Therapeutics, Inc.","slug":"spyre-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcWJLTlpGeGVVNi13ektuWTNZODlhQ0QyWmVPY09ZaHBIVE0wR25YX0xQV19LNHZDLUY1ZDFiUFZIMmR2eFdsRHgxNVBCTzlOa0d0MFhBalV0M0lTVjEtRjJwV3RxbkNmc0ZBUzdyVXhFcXRfd0xhaHp4NnRIV3RFQjF5REg3SWcxTFFuUUR3eEFHcUtqemd1TmZUSi1lbE4xRHpxZ0tpRVZPX3A4T2JxSTR2TER5ZVkwNHpYVDViOW5RZ2NOLXEwQzJRNF9vcFZCMm5DV2JOTWdZTVg2Z0JmX3dWM2NGV3fSAewBQVVfeXFMT3g1RC1LMVpabUdoZUVrMDJnak5SMjJQRzc2c1VSRU5pZERzZ1A2SXJqTkhfbW5iYi00bmJ2RTN5MEFTRjI3b0lyNjA2R2Fsc1ZnMDFybVlXdE5ReTBLZW93a0NyT3NsVlJBa1YyZmQzeXJRV01RTHczdmZsVUJvRnIwVDZIbWZTNFFhT1o4NE0tNUtkR0lpQ19jTkFVQzVMX1c2T1ljbFNFR0xyQ1A0a20teS12d1hOdi1KNzIzQk0zN2FpeFRJSTNFcEpEU1RlTnE4bWJiZk9xa3VFR0UxUlNlUmtTdUxTNWZJNGQ?oc=5","date":"2026-03-30","type":"trial","source":"simplywall.st","summary":"Is Spyre Therapeutics (SYRE) Using Faster RA Trial Timelines To Redefine Its Autoimmune Strategy? - simplywall.st","headline":"Is Spyre Therapeutics (SYRE) Using Faster RA Trial Timelines To Redefine Its Autoimmune Strategy?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNLUpBa05PRzFjajZ4dTVteW9VOFdPSnJ4ZlRXZjhJNGRDVThSZkJSdFFucnNMb1FhWXF1RmpFUmtvcFNZemxYN2ZHLURFX1dUYlNram4tMkFoejQzcVFFR2JoZno0czEtTXd2ZGl4UGVaakpUTU9NbnlZRlNRc1FTQ19zUU5Eby1iUEFIV3RhNWFoMk14SUdnenJkb09ITl8x?oc=5","date":"2026-03-03","type":"pipeline","source":"Stock Titan","summary":"[144] Spyre Therapeutics, Inc. SEC Filing - Stock Titan","headline":"[144] Spyre Therapeutics, Inc. SEC Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wJBVV95cUxQV0plcGRkcFBJdFBicnFxb3hVUmlkYTlvbnhVX3ppQlhDcDljZ3R3MzhYay0wUGRHbWR1Z3A4a3FDSWlnTVdrcWFmaDVEY3dfdFhuRERIUTRsSTYzYnRNU2YxREhUWVVfNS1lZU1Tem9XLTRncFlHQkZGQ0I5N1JKSlU1b0ctanFYQ0ZzWWpCVGp6SHd3aTNTdmc1T3JwMGNOTGhPYS04WHB0VFZDZ0ctRkJQMTdnemFQa2tXVW5nYWR6em5qZVl2M3ZtYmU3UkRDbk42ekVBOEs2d0U5TDZ0cEs0c2dUU2MtbUJMczhaa1hjTERYeGQwNDVGYjJTRS1KOXhhaGdHRDBHS3dTR2c3QTVvcy12YncwVlBPMTE0aTRvLWRPNDdtLVcwSTJuS1RUaUdJbUNtVS0tNXVLcGhRSDFocjlpWFR2ckRnbS1JcXdjZjVNaEFDUkh2YW52N3Q0dEN3?oc=5","date":"2025-06-17","type":"trial","source":"PR Newswire","summary":"Spyre Therapeutics Announces Positive Interim Phase 1 Results for Two Next-Generation TL1A Antibody Programs, and Provides Clinical Development Updates Expected to Deliver 9 Phase 2 Readouts - PR News","headline":"Spyre Therapeutics Announces Positive Interim Phase 1 Results for Two Next-Generation TL1A Antibody Programs, and Provid","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxOYnA5aXpHOFVsWjJvWGZzRFVhV3d5MHd1WVdOU1BOZVlpaElua3FwcndvY1E0WU9fV1BpQlBrZ2FNcUdGMldfV1VORm5XQWVPMkFwd1VwVWlWbWgwd09iQ0dYOUhBLTE0ekFkSkRmSjZFTk9aWHBCYmlwU3pJLTh6MHRka1ViaWQzX29FbXpsbnRXaWpKY0FzQjZPSndydE9qeVphSVhmcUlCRTdtM2lZNk9nLVBhRE9id2RsOUYxQTZEdkF5RHU0RG5GeHdBM2l0Z3EtVGdIZ3o1X1prcmtqRWh5WmVQeS1zUXlUazFvcHBxUGd5NHQtbmt5a1I2cFl0TE5ZaEVVdDRZNVU?oc=5","date":"2025-03-27","type":"trial","source":"PR Newswire","summary":"Spyre Therapeutics Announces First Participant Dosed in Phase 1 Trial of SPY003, its Novel Half-life Extended IL-23 Antibody - PR Newswire","headline":"Spyre Therapeutics Announces First Participant Dosed in Phase 1 Trial of SPY003, its Novel Half-life Extended IL-23 Anti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPNzEySXJ2Si1hbXNhN1dxVm9ZTG1DTEEtR3RHMEc2WUdMRE5sWER3cmV2d1Q4UlpyQmJwZldMQ0o2ekhSaXBOUDJUWTVNb2Jyd2NVMlBEdXcxb1VRM3UzaGFZS0RTU1lRSUFmRU56VG9PNk5CYkJ1LVNubjUtbzFybmNTblBKT0VrOU1JUHNNNkRBLWdudGN0UFkzemltUQ?oc=5","date":"2025-03-04","type":"pipeline","source":"Seeking Alpha","summary":"Spyre Therapeutics: Targeting The Future Of IBD Treatment - Seeking Alpha","headline":"Spyre Therapeutics: Targeting The Future Of IBD Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQVkQ1M3N1ajRkV3E5X3dSUW5wVnpYWmh3Q1daUzBZbUdnQlhJRU5lblNtM0FPc2FLbUNaSjhUT0o2TGp5Tlg0T09zVXFzM2xyUWwyak9RSHg0OU1sQ2FHMTl6cU5pellyeG02OE9hSDc0WTZyV0JmSWt5V2xjWWN2ZktzTThNX3NxUUdmZA?oc=5","date":"2024-12-12","type":"pipeline","source":"Seeking Alpha","summary":"Spyre Therapeutics: Different Name, Same Tune (NASDAQ:SYRE) - Seeking Alpha","headline":"Spyre Therapeutics: Different Name, Same Tune (NASDAQ:SYRE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBBcHpadExCVGg2VFFrNnNzSmpOZDlnWVk1b2MwRFFPSFdFX2ZpcWNLVHJsZWs2bzdiUlN2YW1rcEV5dDRuVUZZSXlpbnM1QzBUR2RmNGpTZGtLZlRqeG0w?oc=5","date":"2024-10-05","type":"pipeline","source":"The Pharma Letter","summary":"Spyre Therapeutics - The Pharma Letter","headline":"Spyre Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNdEIxV2t3SGJoMGthWVNWTXg4emtjN21ycG1kM081aEhHUjNlM0xZLTltWmZYWjRENk5FYm5zbXY2aVhhTE1ITWxwdzhER3MwbzA0cnlfY3d1bnUwYjlLOXBOQnJrdjJFZW1kVXcwc2Joc0o3WUVReG9KeUo3M19wVG1FYVNreTBlLTYtQlVld1FCc0o1cW1ORkg5bW1hZkJRZUxzT2FpWko?oc=5","date":"2023-12-08","type":"pipeline","source":"BioPharma Dive","summary":"Spyre Therapeutics raises $180 million to advance anti-inflammatory drugs - BioPharma Dive","headline":"Spyre Therapeutics raises $180 million to advance anti-inflammatory drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE9KektISzN6QUdVU003ZHZ1WXNCRzVBaXFrMXg5VGlnTWZobzR0M1FNbUFFSDZEbzIzTEFrRWVuRk40WUF0dWNWWVRLOGV4Z0dtNGpLVkYySlVhSzBh?oc=5","date":"2023-11-28","type":"pipeline","source":"TradingView","summary":"SYRE Stock Price and Chart — NASDAQ:SYRE - TradingView","headline":"SYRE Stock Price and Chart — NASDAQ:SYRE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxObGlGY2FVb21iT2U5by1iRk9rRGtYRVQtOW43NGFOTUxmeTNhakUwUzFFWFJPYXo5V194R2FUT2FHcnpzam5zbmEtWktnOHdEZ3EzanY0VEdyVDZZX002dVNhVG16ckM3RjN3YWlyQ0F4b0lmU1NrUUpBaFlNWWlnMVRrWUt3WEZzWFI5RU9LYWtXZw?oc=5","date":"2023-11-27","type":"pipeline","source":"citybiz","summary":"Spyre Therapeutics Appoints Cameron Turtle as CEO - citybiz","headline":"Spyre Therapeutics Appoints Cameron Turtle as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOQUFNUFdaSXN1ZTZMMGh0QV9sRndMaUFqV2dpbXJaVnVmWjRTam5vLU1hMEoxQk4tU2xRZU1CaEsxYjVMSWdNU2pXb3Rpdl9PRDhMNV83TENYR0JHOVFjVkwzYmJUdEpYdkl1YkpkUzhNZnZfYjVsSUZ2Rkk5SDlobzNfQWI?oc=5","date":"2023-11-27","type":"pipeline","source":"Medical Marketing and Media","summary":"Aeglea rebrands to Spyre Therapeutics, names new CEO amid leadership changes - Medical Marketing and Media","headline":"Aeglea rebrands to Spyre Therapeutics, names new CEO amid leadership changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQaTJORUgwLTFTa3RUa3B5SmZTeWh5OHR2NXFUSzJFeFFCa2VUcTVVQVd0d2xESGtFaDYyTGc2dTdob2MwbDU0OE53OWVXckNfaTB5aFNvNHVZOXZyTHF2dzc1ODJnU0JNcG5WZUplOUhpV2lTUjRQNkx2akhPamxnUzhDNmctRldJSzdSUldFdk8?oc=5","date":"2023-06-22","type":"deal","source":"BioPharma Dive","summary":"Spyre, a new biotech spinout, launches via merger with Aeglea - BioPharma Dive","headline":"Spyre, a new biotech spinout, launches via merger with Aeglea","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}